Abiopharma

🔍 Kalia Kumud (Executive)

Company: Guardant Health, Inc. (GH)

Report Date: 2026-03-11

Detailed Transactions and Holdings:

• Acquired 13,632 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 13,632.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: This represents a restricted stock unit award granted on March 11, 2026 that vests over a three-year period. 33% of the shares subject to such award will vest on April 1, 2027 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
• F2: Not applicable for Restricted Stock Units.